Immunology

Blockade at the receptor

When chlamydia attacks the human body, the immune system activates. But the bacteria are adapted to defend themselves. Scientists from Würzburg have deciphered new details of their strategy.

Diseases, Conditions, Syndromes

Study links high community sanitation coverage to lower risk of trachoma

A global study of water and sanitation coverage has found that community access to sanitation facilities exceeding 80 percent reduces rates of trachoma, a blinding eye disease caused by repeated infection with Chlamydia trachomatis. ...

Diseases, Conditions, Syndromes

Study: Site of first chlamydia exposure makes big difference

Exposing the gut to chlamydia protects against subsequent infection in the genital tract and other tissues, researchers from UT Health San Antonio discovered. Chlamydia is the nation's most common sexually transmitted disease ...

Diseases, Conditions, Syndromes

STD treatment for two? Study shows patient value, cost savings

In some states, patients who test positive for chlamydia or gonorrhea leave the clinic with not only a prescription for themselves, but also one for their sexual partner—who was not seen by a doctor.

Diseases, Conditions, Syndromes

Chlamydia more common in New Zealand than thought

One in three New Zealand women have had the sexually transmitted infection (STI) chlamydia by the age of 38 as have one in five men, based on estimates from a new study.

Diseases, Conditions, Syndromes

New chlamydia drug targets discovered using CRISPR and stem cells

Scientists at the Wellcome Trust Sanger Institute and their collaborators at the University of British Columbia have created an innovative technique for studying how chlamydia interacts with the human immune system.

page 4 from 10